Novel rapid- and short-acting hypoglycemic agent, a calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor : comparison of effects between KAD-1229 and gliclazide
収録刊行物
-
- J Pharmacol Exp Ther
-
J Pharmacol Exp Ther 269 489-495, 1994